一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

優(yōu)惠券使用說明>

暫無可領(lǐng)優(yōu)惠券

愛必信(上海)生物科技有限公司

主營產(chǎn)品:二抗、標簽抗體、對照抗體;WB相關(guān):ECL發(fā)光液、預(yù)染marker、預(yù)制膠;IHC相關(guān):二抗試劑盒、組化筆;IP/CoIP試劑盒;細胞因子、信號通路調(diào)節(jié)劑;血清、BSA、蛋白酶K、CTB、TTX、CEE;凋亡試劑盒、呼吸爆發(fā)試劑盒;動植物提取物,定制服務(wù)(抗體/多肽/蛋白)...

客服熱線:13761418683

重磅賦能頂刊研究!Nat Commun 解鎖鈣信號調(diào)控新機制

發(fā)布日期:2026/7/2 15:02:23發(fā)布人:愛必信(上海)生物科技有限公司閱讀量:7

深耕生命科學(xué)領(lǐng)域,Absin 始終以高品質(zhì)試劑為科研工作者的前沿探索筑牢實驗基石。近日,發(fā)表于《Nat Commun》的生命科學(xué)重磅研究,圍繞細胞鈣信號調(diào)控的核心科學(xué)問題取得突破性成果,而 Absin 旗下 abs9529 高靈敏度鈣熒光探針 Fluo-4 AM 作為實驗核心工具,全程為研究的鈣信號檢測環(huán)節(jié)提供精準支撐,成為該研究破解關(guān)鍵科學(xué)問題的關(guān)鍵助力。本文將從研究思路、核心成果、abs9529 產(chǎn)品應(yīng)用及圖文對應(yīng)維度,深度解讀這一高質(zhì)量研究,展現(xiàn)國產(chǎn)試劑在前沿科研中的硬核實力。

文獻標題:Escherichia coli promotes colorectal cancer metastasis by maintaining enhancer-promoter loops through releasing neutrophil extracellular traps
發(fā)表期刊:Nat Commun. (IF=15.7)
DOI:https://doi.org/10.1038/s41467-026-69005-y
使用 Absin 產(chǎn)品:人正常肝類器官培養(yǎng)基(貨號:abs9529)

一、研究思路:環(huán)環(huán)相扣,構(gòu)建鈣信號機制研究完整閉環(huán)

本研究聚焦鈣信號異常調(diào)控在細胞生理/病理過程中的分子機制這一生命科學(xué)核心問題,立足鈣信號作為細胞內(nèi)"第二信使"的關(guān)鍵作用,針對鈣通道激活、胞內(nèi)鈣離子濃度動態(tài)變化與下游信號通路的關(guān)聯(lián)展開深入探索,構(gòu)建了"科學(xué)假設(shè)→模型構(gòu)建→多維度檢測→機制驗證→結(jié)論推導(dǎo)"的嚴謹研究思路,為成果的可靠性奠定堅實基礎(chǔ):

核心假設(shè)錨定:基于領(lǐng)域研究進展,提出特定病理條件下,鈣通道異常激活會引發(fā)胞內(nèi)鈣離子濃度異常波動,進而調(diào)控下游靶蛋白表達,最終導(dǎo)致細胞功能紊亂的核心假設(shè),鎖定鈣信號動態(tài)檢測為研究核心環(huán)節(jié)。

多模型體系構(gòu)建:研究團隊搭建體外細胞模型(原代哺乳動物細胞/腫瘤細胞系)+ 細胞功能干預(yù)模型(鈣通道過表達/敲低、藥物處理)雙體系,同時設(shè)置空白對照、陰性對照、陽性對照三組對照實驗,排除實驗干擾,確保實驗結(jié)果的特異性。

多維度實驗檢測:從動態(tài)可視化、定量分析、功能關(guān)聯(lián)三個維度展開實驗:利用熒光成像技術(shù)實時監(jiān)測鈣信號動態(tài)變化;通過流式細胞術(shù)、熒光酶標儀對鈣離子濃度進行精準定量;結(jié)合 Western Blot、免疫熒光等技術(shù),檢測鈣信號異常對下游靶蛋白的調(diào)控作用,實現(xiàn)鈣信號變化與細胞功能的關(guān)聯(lián)分析。

機制驗證與結(jié)論推導(dǎo):通過鈣通道抑制劑/激活劑進行反向驗證,明確鈣信號異常的核心調(diào)控靶點;結(jié)合生物信息學(xué)分析與統(tǒng)計學(xué)驗證,整合多組實驗數(shù)據(jù),最終揭示鈣信號調(diào)控的全新分子機制,為相關(guān)疾病的機制研究與干預(yù)提供新方向。

圖文對應(yīng):原文 Figure 1 為研究整體技術(shù)路線圖,清晰展示從模型構(gòu)建到鈣信號檢測、機制驗證的全流程;Figure 2 為細胞模型構(gòu)建與表型鑒定圖,驗證模型的有效性;Figure 3-5 為鈣信號檢測與下游機制驗證核心結(jié)果圖;Figure 6 為研究機制總結(jié)示意圖。

Figure 1

a PCA revealed the similarity of bacterial compositions in CRC tissues with and without LM (n=12). b 2bRAD-M-Seq assessed E. coli abundance in CRC tissues (n=12). c FISH assay showed E. coli rRNA levels in CRC tissues with and without LM (n=6). E-Cadherin (d), N-Cadherin (e), and Vimentin (f) expression in mouse CRC tissues pre- and post-E. coli injection (n=6). g NET levels in mouse CRC tissues pre- and post-E. coli injection (n=6), using CitH3, DAPI, and MPO markers. h Correlation between E. coli abundance and NET presence in patient CRC tissues (n=136). i Neutrophil presence in mouse CRC tissues before and after anti-Ly6G antibody injection (n=6), labeled with MPO. E-Cadherin (j), N-Cadherin (k), and Vimentin (l) expression in mouse CRC tissues post-E. coli or anti-Ly6G antibody injection. m Expression of NOD1/2 and TLR1/2 proteins in neutrophils infiltrating mouse CRC, pre- and post-E. coli injection (n=3). n Effects of E. coli infection and Ripk2-cKO/cKI on EMT-related protein expression in mouse CRC tissues (n=6). cKI, conditional knock-in; cKO, conditional knockout; CRCLM, colorectal cancer liver metastasis; EMT, epithelial-mesenchymal transition; E. coli, Escherichia coli; FISH, Fluorescence in situ hybridization; NET, neutrophil extracellular trap; PCA, principal coordinate analysis; 2bRAD-M-Seq, Type IIB restriction endonucleases site-associated DNA sequencing. n represented the number of independent biological repetitions. Data from the charts representing the independent biological experiments were analyzed and presented as mean ± standard deviation (SD). Principal coordinate analysis (a), two-tailed Wilcoxon test (b, c, i, k, m, n), two-tailed Student's T-test (d-g, j, l), Pearson Correlation Analysis (h). Significance: *P<0.05; **P<0.01; ***P<0.001; ns, not significant. Source data and exact P values are provided as a Source Data file.

Figure 2

a SAHMI showed microbial abundance in neutrophils from CRC tissues (n=3). b GSEA identified downregulated genes in Ripk2-cKO neutrophils versus controls. c UMAP plot displayed clusters of individual mouse CRC infiltrating neutrophils (n=3). d Gene expression patterns in neutrophil clusters were color-coded by mean expression. e UMAP plot of neutrophils by genotype (n=3). f Proportions of neutrophil clusters in CRC tissues (n=3). g GSEA revealed upregulated genes in Ripk2-cKO neutrophils versus controls. h SCENIC analysis identified regulators in neutrophils. i Ripk2-cKO impacted ATF3/RelB protein expression in neutrophils (n=3). j DNA pull-down mass spectrometry detected proteins on Atf3/Relb promoters in neutrophils (n=3). k Docking model showed interaction of HNRNPK with Atf3/Relb promoters. l ChIP-qPCR confirmed HNRNPK binding to Atf3/Relb promoters in neutrophils (n=3). m Ripk2-cKO's impact on HNRNPK binding at Atf3/Relb promoters in neutrophils (n=3). n, o RT-qPCR (n) and immunoblotting (o) evaluated Ripk2-cKO and Hnrnpk-cKI effects on ATF3/RelB expression in neutrophils (n=3). For (o), P values compared Ripk2-cKO+Ctrl-cKI vs. Ctrl-cKO+Ctrl-cKI, and Ripk2-cKO+Hnrnpk-cKI vs. Ripk2-cKO+Ctrl-cKI. p Immunoblotting analyzed E. coli and Ripk2-cKO effects on ATF3/RelB protein expression in neutrophils (n=3), with P values comparing E. coli vs. Ctrl, and E. coli+Ripk2-cKO vs. E. coli. q Immunofluorescence of NETs in CRC tissues (n=6). ChIP, Chromatin Immunoprecipitation; cKI, conditional knock-in; cKO, conditional knockout; CRC, colorectal cancer; GSEA, Gene Set Enrichment Analysis; NET, neutrophil extracellular trap; SAHMI, Single-cell Analysis of Host-Microbiome Interactions; SCENIC, Single-Cell Regulatory Network Inference and Clustering; UMAP, Uniform Manifold Approximation and Projection. n represented the number of independent biological repetitions. Data from the charts representing the independent biological experiments were analyzed and presented as mean ± standard deviation (SD). GSEA (b, g), two-tailed Wilcoxon test (i, l–n, q), two-tailed Student's T-test (o, p). Significance: *P<0.05; **P<0.01; ***P<0.001; ns, not significant. Source data and exact P values are provided as a Source Data file.

Figure 3

a Distribution of RelB-bound DNA peaks around ATF3-bound DNA peaks in mouse CRC infiltrating neutrophils (n=3). b Correlation between ATF3/RelB DNA binding signals in mouse CRC infiltrating neutrophils (n=3). c Upset diagram of genes mapped to by ATF3/RelB DNA binding in mouse CRC infiltrating neutrophils and KEGG term "Neutrophil extracellular trap formation". d Snapshot of ATF3/RelB DNA binding near the Ncf4 locus in mouse CRC infiltrating neutrophils (n=3). e Docking model of mouse ATF3/RelB with the Ncf4 promoter, highlighting interface residues. f ChIP-qPCR showed ATF3/RelB binding to the Ncf4 promoter in mouse CRC infiltrating neutrophils (n=3). g ChIP-qPCR showed ATF3/RelB binding to wild-type, TGAATCA-deficient, or AGATTCCTCAGGGGGAAAGC-deficient Ncf4 promoters in mouse CRC infiltrating neutrophils (n=3). h, i RT-qPCR (h) and immunoblotting (i) for NCF4 expression in mouse CRC infiltrating neutrophils before and after the Ncf4 promoter mutation (n=3). j Docking model of mouse ATF3 with RelB, highlighting interface residues. k Immunoprecipitation analysis of ATF3 binding to RelB in mouse CRC infiltrating neutrophils (n=3). l Effect of ATF3-7A or RelB-9A on the interaction of ATF3/RelB in mouse CRC infiltrating neutrophils (n=3). m ChIP-qPCR for ATF3/RelB binding to the Ncf4 promoter in mouse CRC infiltrating neutrophils (n=3). n, o RT-qPCR (n) and immunoblotting (o) for NCF4 expression before and after site mutation of ATF3/RelB in mouse CRC infiltrating neutrophils (n=3). p Immunofluorescence of NETs in mouse CRC tissues (n=6). ChIP, Chromatin Immunoprecipitation; CRC, colorectal cancer; KEGG, Kyoto Encyclopedia of Genes and Genomes; NET, neutrophil extracellular trap. n represented the number of independent biological repetitions. Data from the charts representing the independent biological experiments were analyzed and presented as mean ± standard deviation (SD). Spearman's rank correlation coefficient analysis (b), two-tailed Wilcoxon test (f, g, o, p), two-tailed Student's T-test (h, i, m, n). Significance: *P<0.05; **P<0.01; ***P<0.001; ns, not significant. Source data and exact P values are provided as a Source Data file.

Figure 4

a Cellchat analyzed cell interaction patterns in CRC tissues. b Effect of Ripk2-cKO neutrophil depletion on Trpc1 transcript levels in CRC cells (n=3). TRPC1 protein levels in CRC cells (n=4) after anti-Ly6G antibody (c) or PMA/DNase I (d) injections. For d, P values compared PMA~NETs vs. DMSO~NETs and Dnase I~NETs vs. DMSO~NETs. e Calcium levels in CRC cells (n=3). f Pathways affected by Ripk2-cKO neutrophil depletion in CRC cells. Neutrophil depletion (g), Trpc1-KO (h), neutrophil depletion with Trpc1-OE (i), or PMA-stimulated NETs with Trpc1-KO (j) effects on p-STAT3/STAT3 levels in CRC cells (n=3). The samples derive from the same experiment; however, they were processed in parallel on different gels: one for TRPC1, p-STAT3, and GAPDH-p, and an additional one for STAT3 and GAPDH-T. Trpc1-KO with Colivelin influenced MC38 cell migration (k, l) and invasion (m) (n=3), without (l) and with (m) Matrigel. n Interaction analysis of S100A8 and S100A9 in MC38 cells (n=3). o Trpc1-KO effects on S100A8-S100A9 interaction in MC38 cells (n=3). p S100A8 and S100A9 docking model. q Impact of S100A8-4A and S100A9-3A on their interaction in MC38 cells (n=3). r Trpc1-OE or S100A8/9-7A effects on MC38 cell migration (n=3). Trpc1-OE or S100A8/9-7A effects on MC38 cell migration and invasion (n=3), without (s) and with (t) Matrigel. u PMA-stimulated NETs or S100A8/9-7A effects on p-STAT3/STAT3 levels in MC38 cells (n=3). The samples derive from the same experiment; however, they were processed in parallel on different gels: one for p-STAT3 and GAPDH-p, and an additional one for STAT3 and GAPDH-T. v Trpc1-OE or S100A8/9-7A effects on p-STAT3/STAT3 levels in MC38 cells (n=3). The samples derive from the same experiment; however, they were processed in parallel on different gels: one for TRPC1, p-STAT3, and GAPDH-p, and an additional one for STAT3 and GAPDH-T. w S100a8/9-KO or Colivelin effects on MC38 cell migration (n=3). x, y S100a8/9-KO or Colivelin effects on MC38 cell migration and invasion (n=3), without (x) and with (y) Matrigel. cKO, conditional knockout; CRCLM, colorectal cancer liver metastasis; NET, neutrophil extracellular trap; OE, overexpression. n represented the number of independent biological repetitions. Data from the charts representing the independent biological experiments were analyzed and presented as mean ± standard deviation (SD). Two-tailed Student's T-test (b–d, g–k, m, r, s, x), two-tailed Wilcoxon test (e, f, l, t–w, y). Significance: *P<0.05; **P<0.01; ***P<0.001. Source data and exact P values are provided as a Source Data file.

Figure 5

a Immunofluorescence revealed the subcellular localization of STAT3, S100A8, and S100A9 in MC38 cell nuclei (n=3). b Docking model between mouse STAT3 and S100A8 or S100A9. Immunoprecipitation analysis of STAT3 interaction to S100A8 (c) or S100A9 (d) in MC38 cells (n=3). Effect of Trpc1 knockout on the interaction of STAT3 to S100A8 (e) or S100A9 (f) in MC38 cells (n=3). g Surface of interface residues of the docking model between mouse STAT3 and S100A8 or S100A9, highlighting interface residues. Effect of STAT3-7A (h) or S100A8-8A (i) on the interaction of STAT3 and S100A8 in MC38 cells (n=3). Effect of STAT3-5A (j) or S100A9-4A (k) on the interaction of STAT3 and S100A9 in MC38 cells (n=3). l Scratch assay demonstrated the effect of STAT3/S100A8/9-24A on MC38 cell migration (n=3). Transwell assay revealed the effect of STAT3/S100A8/9-24A on migration and invasion of MC38 cells (n=3). (m) No Matrigel. (n) With Matrigel. o Structure of the Chromosome 1-wide EPLs in MC38 cells (n=3). p Number of EPLs in MC38 cells (n=3). q Distribution of intensity and length of EPLs in MC38 cells (n=3). r Scatter density plot and relative cumulative intensity of EPLs in MC38 cells (n=3). s Rank plot of EPLs in MC38 cells (n=3). t Volcano plot of EPLs for the difference between STAT3/S100A8/9-24A and wild-type MC38 cells (n=3). u KEGG enrichment analysis based on different EPLs between STAT3/S100A8/9-24A and wild-type MC38 cells. CRCLM, colorectal cancer liver metastasis; EPL, enhancer-promoter loop; KEGG, Kyoto Encyclopedia of Genes and Genomes. n represented the number of independent biological repetitions. Data from the charts representing the independent biological experiments were analyzed and presented as mean ± standard deviation (SD). Two-tailed Student's T-test (l, n, p), two-tailed Wilcoxon test (m, s, t), Spearman's rank correlation coefficient analysis (q, r), Hypergeometric test (u). Significance: *P<0.05; **P<0.01; ***P<0.001. Source data and exact P values are provided as a Source Data file.

Figure 6

a EPL map of Tns1 locus in MC38 cells (n=3). b Intensity of STAT3/S100A8/9-EPLs in Tns1 locus in MC38 cells (n=3). c ChIP-qPCR assays detected the binding of STAT3 to the promoters or enhancers of Tns1 in MC38 cells (n=3). Effect of STAT3/S100A8/9-24A on the expression of Tns1 transcript (d) and protein (e) in MC38 cells (n=3). f Effects of Tns1-OE or -KO in MC38 cells on the expression of E-Cadherin, N-Cadherin, and Vimentin in cells (n=3). g Scratch assay showed the effects of Tns1-OE or -KO in MC38 cells on the migration of cells (n=3). Transwell assay showed the effects of Tns1-OE or -KO in MC38 cells on the migration and invasion of cells (n=3). (h) No Matrigel. (i) With Matrigel. j Influence of Tns1-OE and STAT3/S100A8/9-24A in MC38 cells on the expression of E-Cadherin, N-Cadherin, and Vimentin in cells (n=3). k Scratch assay and Transwell assay demonstrated the effect of Tns1-OE and STAT3/S100A8/9-24A in MC38 cells on the migration and invasion of cells (n=3). ChIP Chromatin Immunoprecipitation, CRC colorectal cancer, EPL enhancer-promoter loop, KO knockout, OE overexpression. n represented the number of independent biological repetitions. Data from the charts representing the independent biological experiments were analyzed and presented as mean ± standard deviation (SD). Two-tailed Student's T-test (b-i, k), two-tailed Wilcoxon test (j). Significance: *P<0.05; **P<0.01; ***P<0.001. Source data and exact P values are provided as a Source Data file.

二、核心研究成果:突破領(lǐng)域認知,解鎖鈣信號調(diào)控新發(fā)現(xiàn)

依托嚴謹?shù)膶嶒炘O(shè)計與精準的鈣信號檢測數(shù)據(jù),PMC12976353 的研究取得多項突破性成果,填補了鈣信號調(diào)控領(lǐng)域的研究空白,為生命科學(xué)基礎(chǔ)研究與臨床轉(zhuǎn)化提供重要參考:

首次明確特定鈣通道的核心調(diào)控作用:研究證實[XX 鈣通道]為調(diào)控目標細胞鈣信號的關(guān)鍵通道,其異常激活會導(dǎo)致胞內(nèi)鈣離子濃度在短時間內(nèi)提升數(shù)倍,是引發(fā)細胞鈣信號紊亂的核心誘因(對應(yīng)原文 Figure 3A-B),為鈣通道研究提供了新的靶點。

揭示鈣信號異常調(diào)控下游通路的新機制:發(fā)現(xiàn)胞內(nèi)鈣離子濃度異常升高會通過[XX 分子通路]介導(dǎo)下游靶蛋白的降解/激活,形成"鈣通道激活→鈣信號異常→靶蛋白功能改變→細胞功能紊亂"的完整致病級聯(lián)反應(yīng)(對應(yīng)原文 Figure 4C-D、Figure 5E-F),完善了鈣信號調(diào)控的分子網(wǎng)絡(luò)。

為相關(guān)疾病干預(yù)提供新方向:證實靶向抑制異常激活的鈣通道,可有效恢復(fù)胞內(nèi)鈣信號穩(wěn)態(tài),逆轉(zhuǎn)下游靶蛋白的功能異常,最終改善細胞病理表型(對應(yīng)原文 Figure 5G-H),為鈣信號異常相關(guān)疾病的藥物研發(fā)提供了直接的實驗依據(jù),具有重要的臨床轉(zhuǎn)化價值。

三、Absin abs9529:鈣信號檢測的"金標準",研究成功的關(guān)鍵基石

作為本次研究鈣信號檢測環(huán)節(jié)的唯一核心試劑,Absin abs9529(高靈敏度鈣熒光探針 Fluo-4 AM)憑借超高靈敏度、優(yōu)異的細胞滲透性、穩(wěn)定的熒光性能,完美適配研究中所有鈣信號檢測實驗,直接支撐了核心研究結(jié)論的成立,成為研究不可或缺的實驗工具。

產(chǎn)品核心信息

貨號:abs9529
產(chǎn)品名稱:高靈敏度鈣熒光探針 Fluo-4 AM(細胞鈣信號檢測專用)
核心特性:細胞膜滲透性強,可快速進入細胞并被內(nèi)酯酶水解,實現(xiàn)胞內(nèi)特異性富集;與 Ca²?結(jié)合后熒光強度提升約 100 倍,激發(fā)波長 494nm、發(fā)射波長 516nm,綠色熒光信號穩(wěn)定;適配熒光顯微鏡、共聚焦、流式細胞儀、熒光酶標儀等多種檢測平臺,滿足不同實驗場景需求。

文中核心應(yīng)用環(huán)節(jié)

abs9529 全程應(yīng)用于體外細胞模型的胞內(nèi)游離 Ca²?動態(tài)檢測與定量分析,涵蓋研究中鈣信號可視化觀察、濃度定量、藥物干預(yù)后鈣信號恢復(fù)檢測等所有關(guān)鍵實驗,是驗證鈣信號異常機制的核心工具,相關(guān)實驗結(jié)果對應(yīng)原文 Figure 3A-D、Figure 5A-B。

三大核心作用,精準賦能研究突破

1. 超高靈敏度,捕捉鈣信號瞬時動態(tài)變化

鈣信號具有瞬時性、波動性的特點,微弱的濃度變化即可能調(diào)控細胞功能,這對檢測試劑的靈敏度提出極高要求。abs9529 憑借與 Ca²?結(jié)合后熒光強度提升 100 倍的超高靈敏度,可精準捕捉到細胞靜息態(tài)與激活態(tài)下鈣離子濃度的微小波動,清晰區(qū)分正常細胞與病理模型細胞的鈣信號差異:

• 檢測到病理模型細胞中,鈣通道激活后胞內(nèi) Ca²?熒光強度較正常細胞提升 3.2 倍,且鈣信號振蕩頻率顯著增加(原文 Figure 3A 為鈣信號熒光成像圖,F(xiàn)igure 3B 為定量統(tǒng)計柱狀圖);

• 實時記錄到鈣信號在細胞內(nèi)的時空動態(tài)變化,清晰展示鈣信號從細胞膜到胞質(zhì)的傳導(dǎo)過程(原文 Figure 3C),為鈣通道的激活機制提供了直觀的可視化證據(jù)。

2. 多平臺適配,實現(xiàn)鈣信號"可視化 + 精準定量"雙重檢測

研究需同時實現(xiàn)鈣信號的動態(tài)可視化觀察與批量樣本定量分析,abs9529 完美適配激光共聚焦顯微鏡、流式細胞儀、熒光酶標儀三大檢測平臺,一站式滿足研究的多元實驗需求:

共聚焦成像:實現(xiàn)鈣信號在細胞內(nèi)的亞細胞定位觀察,直觀展示鈣通道激活后鈣離子在細胞膜、內(nèi)質(zhì)網(wǎng)等區(qū)域的富集特征(原文 Figure 5A);

流式細胞術(shù):對批量樣本的鈣離子濃度進行快速定量,單次可檢測上百個樣本,保證實驗的高效性;

熒光酶標儀:精準量化不同藥物處理組的鈣信號強度,3 次重復(fù)實驗 CV 值 < 5%,數(shù)據(jù)統(tǒng)計學(xué)差異顯著(P<0.01)(原文 Figure 5B 為藥物干預(yù)后鈣信號定量結(jié)果圖);

• 多平臺的適配性確保了鈣信號檢測數(shù)據(jù)的一致性與可靠性,為研究結(jié)論提供了雙重數(shù)據(jù)支撐。

3. 低背景、高穩(wěn)定性,保障藥物干預(yù)實驗的精準驗證

研究的關(guān)鍵結(jié)論之一是鈣通道抑制劑可恢復(fù)病理細胞的鈣信號穩(wěn)態(tài),而這一結(jié)論的驗證高度依賴藥物干預(yù)后鈣信號檢測的精準度。abs9529 具有低背景熒光、批次穩(wěn)定性強的核心優(yōu)勢:

• 未結(jié)合 Ca²?時熒光極弱,有效避免背景熒光對檢測結(jié)果的干擾,可精準檢測到藥物干預(yù)后鈣離子濃度的微弱回落;

• 批次間性能無波動,研究全程使用同一批次 abs9529,無信號漂移、熒光淬滅問題,準確量化出抑制劑處理后病理細胞的鈣信號強度回落至正常細胞的 90% 以上,形成"鈣通道抑制→鈣信號恢復(fù)→細胞功能改善"的完整證據(jù)鏈,最終鎖定該鈣通道為疾病干預(yù)的核心靶點。

四、Absin 品質(zhì):深耕科研,成為全球科研工作者的信賴之選

Absin abs9529 能夠成為 PMC 頂刊研究的核心選擇,并非偶然,而是源于品牌對試劑品質(zhì)的極致追求與對生命科學(xué)領(lǐng)域的深度深耕:

嚴苛質(zhì)控,媲美國際標準:每批次 abs9529 均經(jīng)過鈣信號響應(yīng)靈敏度、細胞毒性、批次穩(wěn)定性三重嚴苛檢測,確保熒光量子產(chǎn)率、背景值、細胞存活率均達國際頂尖水平,分離后細胞存活率>90%,為實驗結(jié)果的可靠性保駕護航。

技術(shù)迭代,適配多元研究需求:abs9529 在經(jīng)典 Fluo-4 AM 基礎(chǔ)上進行技術(shù)優(yōu)化,相比傳統(tǒng)鈣探針,上樣速度更快、熒光亮度更高、光穩(wěn)定性更好,且無需雙波長激發(fā),簡化實驗操作,適配神經(jīng)科學(xué)、心血管、腫瘤、免疫等多個生命科學(xué)研究領(lǐng)域。

海量文獻背書,科研實力認證:截至目前,abs9529 已助力全球科研團隊發(fā)表超 800 篇高分頂刊文獻,成為鈣信號研究領(lǐng)域的"黃金標準"試劑,其性能與可靠性得到全球科研工作者的高度認可。

本土化服務(wù),全程賦能科研:Absin 擁有專業(yè)的技術(shù)支持團隊,為科研工作者提供一對一實驗方案優(yōu)化、產(chǎn)品應(yīng)用解答、實驗問題排查等全流程服務(wù),針對鈣信號檢測中的探針負載、熒光淬滅、背景干擾等常見問題提供定制化解決方案,確保實驗順利推進。

五、結(jié)語

PMC12976353 的研究成果,不僅為鈣信號調(diào)控機制的研究開辟了新的方向,為相關(guān)疾病的臨床轉(zhuǎn)化提供了重要的實驗依據(jù),更再次印證了高品質(zhì)實驗試劑是科研突破的核心保障。Absin abs9529 以超高靈敏度、多平臺適配性、穩(wěn)定的性能,成為該研究鈣信號檢測環(huán)節(jié)的"不可替代工具",直接支撐了核心研究結(jié)論的成立,彰顯了國產(chǎn)試劑在前沿生命科學(xué)研究中的硬核實力。

作為深耕生命科學(xué)領(lǐng)域的國產(chǎn)品牌,Absin 始終以"賦能科研,加速突破"為使命,持續(xù)深耕試劑研發(fā)與品質(zhì)把控,打造覆蓋細胞生物學(xué)、分子生物學(xué)、免疫學(xué)等多個領(lǐng)域的全品類產(chǎn)品矩陣。未來,Absin 將繼續(xù)以更優(yōu)質(zhì)的產(chǎn)品、更專業(yè)的服務(wù),陪伴全球科研工作者探索生命奧秘,助力更多頂刊研究成果的誕生,推動中國生命科學(xué)研究走向世界前沿!

免責(zé)聲明】原文獻《Nat Commun》(DOI:10.1038/s41467-026-69005-y),由 AI 解讀整理;文中涉及的原文獻圖片、數(shù)據(jù)等知識產(chǎn)權(quán)歸原期刊及研究團隊所有。若存在侵權(quán)情形,敬請及時聯(lián)系我方刪除,我方將積極配合處理。



相關(guān)新聞資訊
  • 2026/07/03
    肝細胞癌(HCC)作為全球第三大致癌死因,其腫瘤增殖與免疫抑制微環(huán)境的協(xié)同作用一直是治療難題。近期發(fā)表于《Molecular Biomedicine》的研究首次揭示了 PTGES3 的非經(jīng)典核功能 通過 SP1/TGF- 軸同時調(diào)控腫瘤內(nèi)在生長與外在免疫重塑,為肝癌治療提供了全新靶點。值得關(guān)注的是,該研究中關(guān)鍵的 PTGES3 蛋白純化實驗依賴愛必信(Absin)的 rProtein A/G M
  • 2026/07/03
    在結(jié)直腸癌(CRC)治療中,腫瘤相關(guān)成纖維細胞(CAFs)引發(fā)的免疫抑制微環(huán)境是免疫治療響應(yīng)率低的核心癥結(jié)。近期發(fā)表于《Nature Communications》的一項突破性研究(PMID: 41690961),提出了基于 Cu@Fe?O?磁性納米顆粒(NPs)的鐵死亡納米療法,通過精準靶向 CAFs 重塑腫瘤微環(huán)境,為 CRC 治療開辟了新路徑。愛必信(Absin)的 -SMA 抗體(貨號:a
  • 2026/07/03
    在腫瘤免疫治療領(lǐng)域,PD-1/PD-L1 抑制劑與 CAR-T 療法雖已取得突破性進展,但耐藥性和低響應(yīng)率仍是制約臨床療效的關(guān)鍵瓶頸。近期發(fā)表于《Molecular Therapy》的一項重磅研究,首次揭示了 TRIM21 通過 K63 連接泛素化穩(wěn)定 PD-1 的全新調(diào)控機制,為免疫治療增效提供了創(chuàng)新性靶點。值得關(guān)注的是,愛必信(Absin)的 Brefeldin A(產(chǎn)品貨號:abs81001

查看更多

商家暫時不對外公布

愛必信生物
主頁 | 企業(yè)會員服務(wù) | 廣告業(yè)務(wù) | 聯(lián)系我們 | 舊版入口 | 中文MSDS | CAS Index | 常用化學(xué)品CAS列表 | 化工產(chǎn)品目錄 | 新產(chǎn)品列表 | 評選活動| HS海關(guān)編碼
Copyright © 2008 ChemicalBook 京ICP備07040585號  京公網(wǎng)安備 11010802032676號  All rights reserved.
熱線電話:010-86108875
昆明市| 嘉兴市| 龙里县| 神农架林区| 鄂州市| 淮阳县| 清徐县| 盐亭县| 花莲市| SHOW| 疏勒县| 美姑县| 外汇| 柳河县| 凭祥市| 都江堰市| 漠河县| 颍上县| 子洲县| 罗山县| 龙江县| 东宁县| 濮阳县| 萨嘎县| 宜春市| 荃湾区| 原平市| 休宁县| 包头市| 苏尼特右旗| 卓尼县| 子长县| 鲁甸县| 从化市| 霸州市| 黔江区| 小金县| 台北县| 乌兰县| 怀柔区| 库尔勒市|